Clinical trial
Randomized, Double-blind, Multicenter, Phase III Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza
NCT06528444 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria y Biomédica de Alicante as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Multicenter, Phase III Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza
- Lead sponsor
- Instituto de Investigación Sanitaria y Biomédica de Alicante
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- October 1, 2024
- Completion date
- October 31, 2028
- Enrollment
- 42 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
influenza